The Role of Anti-angiogenic Therapy in the Management of Gynecologic Malignancies: A Review.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 77, doi. 10.13032/tjop.2052-5931.100116.
- By:
- Publication type:
- Article
Works matching IS 20525931 AND DT 2015 AND VI 3 AND IP 1
Results: 6
1
2
Mechanisms of Resistance to ALK-inhibitor Agents.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 67, doi. 10.13032/tjop.2052-5931.100115
- By:
- Publication type:
- Article
3
The Role of Surgery in Malignant Pleural Mesothelioma.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 41, doi. 10.13032/tjop.2052-5931.100120.
- By:
- Publication type:
- Article
4
Overcoming Phosphatidylinositol 3-Kinase PI3K) Activation in Breast Cancer: Emerging PI3K Inhibitors.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 27, doi. 10.13032/tjop.2052-5931.100107
- By:
- Publication type:
- Article
5
Radium-223 Dichloride (Ra-223) for the Treatment of Metastatic Castration-resistant Prostate Cancer: Optimizing Clinical Practice in Nuclear Medicine Centers.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 1, doi. 10.13032/tjop.2052-5931.100121
- By:
- Publication type:
- Article
6
Second Line Treatment in EGFR/ALK-NSCLC Patients.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 55, doi. 10.13032/tjop.2052-5931.100119
- By:
- Publication type:
- Article